Dimensional Fund Advisors’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Dimensional Fund Advisors’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-231,417	Closed	-$209	–	3522
2022 Q4	$209	Sell	231,417 -44,849	-16%	-$130K	﹤0.01%	3219
2022 Q3	$1.66M	Buy	276,266 +39,731	+17%	+$225K	﹤0.01%	2765
2022 Q2	$979K	Buy	236,535 +16,671	+8%	+$58.8K	﹤0.01%	2917
2022 Q1	$835K	Buy	219,864 +17,180	+8%	+$77.4K	﹤0.01%	3032
2021 Q4	$912K	Sell	202,684 -30,079	-13%	-$153K	﹤0.01%	3048
2021 Q3	$1.08M	Buy	232,763 +54,765	+31%	+$290K	﹤0.01%	3034
2021 Q2	$1.25M	Buy	177,998 +125,745	+241%	+$678K	﹤0.01%	2984
2021 Q1	$309K	Buy	+52,253	New	+$317K	﹤0.01%	3220

Other funds holding STSA

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Dimensional Fund Advisors's STSA Position: Q1 2023 in Review

Dimensional Fund Advisors sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q1 2023, closing a stake of 231,417 shares — an estimated $209 sold.

Dimensional Fund Advisors first reported a position in STSA in Q1 2021 and held it in 8 quarters. The position peaked at $1.66M in Q3 2022. 31 funds tracked by Wall St. Rank hold STSA as of Q1 2023.

Dimensional Fund Advisors reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Dimensional Fund Advisors sold 231,417 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $209.
Dimensional Fund Advisors first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Dimensional Fund Advisors's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $1.66M in Q3 2022.
31 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.